Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,302.00
(
0.70%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.54
(
-0.11%
)
Bitcoin
74,193.22
(
0.34%
)
News Focus
News Focus

Replies to post #143354 on Biotech Values

Replies to #143354 on Biotech Values
icon url

dav1234

06/06/12 10:35 AM

#143355 RE: DewDiligence #143354

maybe..HUMIRA is an amazing cash cow, can't last forever
icon url

biomaven0

06/06/12 11:13 AM

#143359 RE: DewDiligence #143354

Those Actemra monotherapy results look very impressive to me.

had a DAS28 remission rate of 40 percent with ACTEMRA versus 11 percent with adalimumab (DAS28 <2.6)



Peter